Similar articles

• [Gastrointestinal complications caused by NSAIDs. Over 60% of arthrosis patients are endangered].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2003 Mar 6;145(10):60. MMW Fortschr Med. 2003. PMID: 12688036 German. No abstract available.
• [Celebrex: confirmed effectiveness and safety (new data)].

  Nasonov EL. Nasonov EL. Ter Arkh. 2001;73(5):57-61. Ter Arkh. 2001. PMID: 11517753 Review. Russian. No abstract available.
• [Gastroduodenal tolerance of celecoxib (celebrex) in patients with osteoarthrosis: an endoscopic evaluation].

  Karateev AE. Karateev AE. Ter Arkh. 2001;73(5):63-4. Ter Arkh. 2001. PMID: 11517755 Russian. No abstract available.
• Coxibs and cardiovascular risk.

  Allen MJ, McLean-Veysey P, Fleming I. Allen MJ, et al. CMAJ. 2005 Oct 11;173(8):853. doi: 10.1503/cmaj.1050119. CMAJ. 2005. PMID: 16217098 Free PMC article. No abstract available.
• [Current post-marketing information. Effects and adverse effects of celecoxib].

  Schmidt H, Geisslinger G. Schmidt H, et al. Pharm Unserer Zeit. 2002;31(2):180-7. doi: 10.1002/1615-1003(200203)31:2<180::AID-PAUZ180>3.0.CO;2-W. Pharm Unserer Zeit. 2002. PMID: 11977454 Review. German. No abstract available.